NYSE:ANTX
Delisted
Anthem Inc Stock Company Profile
$56.86
+0 (+0%)
At Close: May 16, 2018
Information
1800 El Camino Real, Suite D
Menlo Park CA 94027
650-331-9090
www.an2therapeutics.com
Industry: Biotechnology
Sector: Healthcare
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.